Last November, Novo Nordisk announced it would stop selling the injectable FlexPen version of Levemir this month and halt sales of Levemir vials by December 2024. The decision to discontinue ...
Novo Nordisk is discontinuing one of its discounted ... the insulin maker plans to discontinue U.S. sales of the FlexPen version of Levemir in April 2024 and Levemir vials by the end of December.
The new PenCycle programme covers Novo Nordisk's FlexPen and FlexTouch devices, which are used to dispense insulin and other medications. Users of the devices in the UK will shortly be able to ...